Olymvax Biopharmaceuticals (688319.SH) Stock Community - Hot Topic Discussions - Longbridge

Quote List Quote List

Event Tracking

Oct29

Olymvax Biopharmaceuticals released FY2025 9 Months Earnings on October 29 After-Market (BJT), actual revenue CNY 506.92M, actual EPS CNY 0.1171

01:00

Olymvax Biopharmaceuticals released FY2025 Q3 earnings on October 29 After-Market (BJT), actual revenue CNY 201.07 M, actual EPS CNY 0.0842

01:00

Oct22

Olymvax Biopharmaceuticals FY2025 Q3 Earnings Release on October 30, After-Market (BJT)

01:08

Aug28

Olymvax Biopharmaceuticals released FY2025 Semi-Annual Earnings on August 28 Pre-Market (BJT), actual revenue CNY 305.85 M, actual EPS CNY 0.0326

01:00

Olymvax Biopharmaceuticals released FY2025 Q2 earnings on August 28 Pre-Market (BJT), actual revenue CNY 218.36 M, actual EPS CNY 0.0502

01:00

Aug21

Olymvax Biopharmaceuticals to Release FY2025 Semi-Annual Earnings on August 29, 2025 (BJT)

00:27

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 201.07 M, Net Income 34.28 M, EPS 0.0842

Aug29

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 218.36 M, Net Income 20.27 M, EPS 0.0502

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More